Washington University School of Medicine
St Louis, Missouri, 63110, United States
NCT Number: NCT02613325
The investigators propose the use of functional photoacoustic microscopy (fPAM) to evaluate both benign and malignant pigmented lesions for tumor depth. Through fPAM analysis followed by histological examination, the investigators anticipate that they will be able to non-invasively determine tumor depth of pigmented lesions (moles and melanoma). In melanoma, tumor depth (Breslow's depth) is not only an important prognostic indicator, but also directs surgical treatment. The ultimate goal is to develop a sensitive clinical tool that will allow non-surgical evaluation of pigmented lesions, which eventually, will aid in melanoma diagnosis and management - potentially an earlier and more definitive surgical management.
In addition, the investigators propose to use the combination of fPAM and single-cell PAM to respectively image CTCs in trunk vessels and cuticle capillaries. Based on the investigators' murine models, the investigators anticipate that they will be able to differentiate CTCs from other blood cells and reliably calculate CTC concentration in a non-invasive manner. CTC concentration has been demonstrated to be a valuable indicator of a melanoma's metastatic potential and a potential tool in evaluating treatment efficacy. The ultimate goal is to develop a sensitive imaging device that will allow accurate evaluation of the risk of melanoma recurrence and metastases, that may facilitate treatment monitoring.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
St Louis, Missouri, 63110, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Outcome Measure #1 and #2
Outcome Measures #3 and #4
Exclusion criteria
-Hybrid imaging technique that detects absorbed diffusive protons ultrasonically through the photoacoustic effect.
Other names: fPAM
Other names: Single cell PAM
Time frame: Up to 2 weeks
Time frame: Up to 2 weeks
-The thickness as measured by fPAM will be compared with the thickness of the formalin fixed excised lesion.
Time frame: Up to 2 weeks
Time frame: Up to 2 weeks
Washington University School of Medicine
Other
Pilot Study to Determine the Feasibility and Functionality of fPAM Imaging for the in Vivo Depth Measurement of Pigmented Lesions and Melanoma Depth
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04566302
Neoplasms, Neoplasms by Histologic Type
Boston, Massachusetts, United States
View Trial DetailsNCT04202419
Pigmented Skin Lesion
Miami, Florida, United States
View Trial DetailsNCT02848742
Pigmented Skin Lesion
Walnut Creek, California, United States
View Trial DetailsNCT02718066
Adenocarcinoma, Bronchial Neoplasms
Phoenix, Arizona, United States
View Trial Details